High Performance Liquid Chromatography of Mouse Monoclonal Antibodies on Spherical Hydroxyapatite Beads

Abstract

High performance liquid chromatography (HPLC) on newly developed spherical beads of hydroxyapatite was applied for the simple purification of monoclonal antibodies (mAbs) secreted into mouse ascitic fluid. Sixteen mAbs including all four subclasses of IgG and IgM were separated successfully from serum albumin a major contaminant in the crude mAb preparation by a 30 min-linear gradient of phosphate ion concentration from 0.01M-0.3M at pH 7.2. Not only IgG mAbs but also IgM mAbs were quantitatively eluted from the column. Each antibody had a different retention time (apparent capacity factor of 2.24–4.14) in the chromatography and no relation was found between the retention time and the type of immunoglobulin (class or subclass). A monomeric form of IgM was also resolved successfully from IgM (pentamer) after its reduction with dithiothreitol; the monomer form of IgM was eluted from the column by a lower concentration of phosphate ion than was the pentamer. These results indicate that HPLC on the hydroxylapatite beads will be useful for the purification and characterization of mouse mAbs.     

An Improved Method for the Purification of Hepatic Proliferation Inhibitor by Anion-Exchange HPLC

Abstract

An improved method for the purification of hepatic proliferation inhibitor from rat liver by means of anion-exchange HPLC has been developed. The inhibitor can be purified on an anion exchange HPLC column by using a linear sodium phosphate gradient. The HPLC method allows repeated use of one column and is both rapid and reproducible. The hepatic proliferation inhibitor isolated by this method retains all of its biological activity and is homogeneous as revealed by reverse-phase HPLC.     

Rapid Purification of the Unstable Enzyme Carbamoyl Phosphate Synthase by High Pressure Liquid Chromatography

Abstract

Extracts of soluble proteins obtained from rat liver mitochondria by freeze-thawing and subsequent diafiltration were fractionated by HPLC on a I 250 protein column. The column was eluted either with 0.05 M phosphate buffer pH 6.85 or 0.1 M acetate buffer pH 7.15. Specific fractions obtained by elution with either phosphate or acetate buffer showed a 6.1-fold or 5.5-fold increase in the specific activity of Carbamoyl phosphate synthase when compared with that of crude mitochondrial preparations. The purification and the molecular weight of carbamoyl phosphate synthase were verified by sodium dodecyl sulphate-polyacrylamide gel electrophoresis.     

Use of chemically-bonded cyclodextrin stationary phase for high performance liquid chromatographic determination of feldene capsules

A novel high performance liquid chromatographic method (HPLC) is presented for the quantitative determination of piroxicam in capsule formulation (Feldene capsule). Samples are separated on a chemically bonded beta-cyclodextrin column (Cyclobond I) with a mobile phase of 75% 0.05M phosphate buffer (pH 7.0) and 25% methanol. The effluent is monitored by a spectrophotometric detector with a 254-nm filter. The method is rapid, accurate, and precise.     

Purification of the glycoprotein glucose oxidase from Penicillium amagasakiense by high-performance liquid chromatography

Fast protein liquid chromatography (FPLC) in combination with ion-exchange chromatography on a Mono Q column was used to purify glucose oxidase from Penicillium amagasakiense to homogeneity. Purification was performed with a mixed pH and salt gradient, with 20 mM phosphate buffer (pH 8.5) as starting buffer (A) and 50 mM acetate buffer (pH 3.6) with 0.1 M NaCl as elution buffer (B). Elution conditions were optimized to permit the simultaneous purification and separation of the glucose oxidase isoforms. Three peaks, each consisting of 1-2 isoforms and exhibiting a homogeneous titration curve profile, were resolved with a very flat linear gradient of 5.0-5.1% B in 40 ml. Three more peaks, each consisting of several isoforms, were eluted at 10%, 30% and 100% B. Optimization of the elution conditions and separation of the glucose oxidase isoforms was only possible because of the rapidity of each purification step and the high resolution provided by FPLC and Mono Q.     

High-Performance Liquid Chromatographic Determination of Atenolol in Tablets

Abstract

A reversed phase high-performance liquid chromatographic method was developed for the determination of atenolol in four oral 100 mg atenolol preparations.

An aliquot of the sample is dissolved in a mobile phase consisting of 0.0612 M potassium hydrogen phosphate - isopropanol-tetrahydrofuran (84:10:6) v/v). The pH was adjusted to 6.7 with phosphate buffer. Nicotinamide was used as internal standard and chromatographed on a Pinkerton column ISRP (GFF-S5–80) 5 μm, 150 × 4.6 mm i.d. The applied column is convenient for the assay at least 90 samples of atenolol without degrading column performance. The detection was performed at 272 nm. The retention time for atenolol was 5.07 min.

The proposed HPLC method was found to be suitable for the rapid and precise routine analysis of atenolol in tablets.     

Identification of Nitrogenous Organic Compounds in Aquatic Sources by Stopped-Flow Spectral Scanning Technique

Abstract

The presence of nitrogenous organic compounds in raw water sources for municipal supplies is of environmental concern because many of them exert significant chlorine demand (1), while some produce complex stable mutagenic products upon chlorination (2, 3) or are precursors in haloform formation (1). To assist in assessing the importance of this problem high performance liquid chromatography (HPLC) was utilized to identify trace quantities of N-organic contaminants in concentrated samples of municipal water supplies of northeastern Massachusetts. Chromatographic resolution of complex mixtures was achieved on a reversed phase column (Zorbax C-8, DuPont Co.) using a 0.05 M phosphate buffer (pH = 6.9) or a 0.05 M borate buffer (pH = 8.9) to 50% methanol gradient. Constituents of concentrated samples were identified by the amount of time required for elution from the analytical column (retention position), and the positions of maximum and minimum U.V. absorbances, which were measured by stoppedflow spectral scanning of resolved chromatographic peaks. A fluorometric monitor utilizing fluorescamine and borate buffer revealed groups of primary amine compounds not detectable by U.V. spectroscopy.     

Isomers of uroporphyrin free acids separated by HPLC

A synthetic mixture of uroporphyrin isomers I, II, III and IV as free acids in the synthetic ratio of 1:1:4:2 was resolved by reverse-phase HPLC using a C0:PEL (ODS) 37-50 micron precolumn and a Micro Bondapak C18 analytical column eluted with acetonitrile (4%) in phosphate buffer (pH 6.95). Clinically important I and III isomers of uroporphyrin were readily resolved directly from acidified urine as porphyrin free acids.     

Determination of the active metabolites of sibutramine in rat serum using column-switching HPLC

A simple and direct analysis using column-switching HPLC method was developed and validated for the quantification of active metabolites of sibutramine, N-mono-desmethyl metabolite (metabolite 1, M1) and N-di-desmethyl metabolite (metabolite 2, M2) in the serum of rats administered sibutramine HCl (5.0 mg/kg, p.o.). Rat serum was directly injected onto the precolumn without sample prepreparation step following dilution with mobile phase A, i. e., methanol-ACN-20 mM ammonium phosphate buffer (pH 6.0 with phosphoric acid) (8.3:4.5:87.2 by volume). After the endogenous serum components were eluted to waste, the system was switched and the analytes were eluted to the trap column. Active metabolites M1 and M2 were then back-flushed to the analytical column for separation with mobile phase B, i. e., methanol-ACN-20 mM ammonium phosphate buffer (pH 6.0 with phosphoric acid) (35.8:19.2:45 by volume) and detected at 223 nm. The calibration curves of active metabolites M1 and M2 were linear in the range of 0.1-1.0 microg/mL and 0.15-1.8 microg/mL. This method was fully validated and shown to be specific, accurate (10.4-10.7% error), and precise (1.97-8.79% CV). This simple and rapid analytical method using column-switching appears to be useful for the pharmacokinetic study of active metabolites (M1 and M2) of sibutramine.     

HPLC determination of a new multidrug resistance modulator (S9788) extracted from cancer cells in vitro

S9788 is a novel triazinodiaminopiperidine derivative which reverses the multidrug resistance of tumour cells to anticancer drugs. In this study, a new HPLC method was developed to determine this compound in P388 leukaemia cells. The influence of various parameters (composition and pH of the mobile phase, nature of the column) on the separation of S9788 and derivatives was investigated. Using a microsphere C18 column and the optimal mobile phase (acetonitrile-0.4 M phosphate buffer containing 0.2% triethylamine, 40:60 v/v, pH 6.5) it was possible to separate S9788 and seven hypothetical metabolites and derivatives in 15 min. The limits of detection and quantification of S9788 are 75 and 250 pg, respectively. This MDR modulator was extracted from biological media by a rapid two-step procedure which removed proteins before direct injection of the sample. Absolute recoveries ranged from 90 to 100% with a mean RSD (%) lower than 5.     

High-performance liquid chromatographic assay for pteroylpolyglutamate hydrolase

A highly sensitive assay for pteroylpolyglutamate hydrolase is described employing high-performance liquid chromatography (HPLC) with ultraviolet detection at 280 nm. The method is based on the separation of pteroylpolyglutamates containing various glutamyl residues on a C18 muBondapak reversed-phase column. Individual pteroylpolyglutamates are eluted by a gradient of 2.5-8.5% acetonitrile in 0.1 M potassium phosphate buffer (pH 6.0) within 20 min. The polyglutamates with higher glutamyl residues were less well retained in the reversed-phase column. The relationship between the peak area and the amount of pteroylpolyglutamate was observed to be linear over the range 10 pmol to 2.5 nmol. Human serum pteroylpolyglutamate hydrolase was studied using pteroylpentaglutamate as substrate in 0.1 M sodium acetate buffer (pH 4.5). The enzyme appeared to function as an exopeptidase based on the detection of intermediates, pteroyltetra-, tri-, and -diglutamate, and the product, pteroylmonoglutamate. Using the HPLC assay, extracts of Plasmodium falciparum were found not to contain detectable enzyme activity.     

Simultaneous Determination of Caffeine and Antipyrine in Plasma and Saliva using High-Performance Liquid Chromatography

Abstract

A rapid and sensitive method of quantitation of caffeine and antipyrine in plasma and saliva is described. Caffeine, antipyrine and phenacetin, the internal standard, are readily extracted from alkalinized plasma and saliva into dichloromethane. After evaporation of the organic solvent, the residue is analyzed by HPLC using a mobile phase of 25% acetonitrile in 0.02 M phosphate buffer at a flow rate of 1.5 ml/min. and a C18 reverse phase column. Baseline separation of all peaks is achieved with retention times for all compounds of less than 10 minutes. There is no interference from endogenous compounds or metabolites of caffeine or antipyrine.     

Automated high-performance liquid chromatographic determination of 5-S-cysteinyl-3,4-dihydroxyphenylalanine in urine

An automated high-performance liquid chromatographic (HPLC) method has been developed for measurement of 5-S-cysteinyl-DOPA in urine (DOPA = 3,4-dihydroxyphenylalanine). The urinary sample was injected into an HPLC boronate column. With a mobile phase of 0.1 M phosphate buffer containing 0.2 mM disodium ethylenediaminetetraacetate (Na2EDTA) (pH 6.0) mixed with methanol (9:1), 5-S-cysteinyl-DOPA was adsorbed while most other compounds were washed away. By column switching, the column flow was reversed and 5-S-cysteinyl-DOPA was desorbed by a mobile phase of 0.1 M formic acid and 0.2 mM Na2EDTA at pH 3.0 and chromatographed on a reversed-phase column. The precision, as estimated from repeated analysis of an urinary sample and from duplicate analysis of a number of samples, ranged from 1.4 to 5.2% (coefficient of variation), and the analytical recovery was 93 +/- 4.1%. The method is suitable for use in the clinical laboratory.     

Detection of Sulfamethazine Residues in Milk by High Performance Liquid Chromatography

Abstract

A simple high performance liquid chromatographic (HPLC) procedure for the detection of sulfamethazine residues in milk is described. Milk is extracted with chloroform, the extract evaporated to dryness and then redissolved in potassium phosphate buffer (pH 5.0). The chloroform extract, in buffer, is passed through a cyclobond I solid phase extraction (SPE) column. The SPE column is washed with 10 ml potassium phosphate buffer and then sulfamethazine is eluted with 2 ml aqueous (50%) methanol. The eluent is directly analyzed by HPLC with uv detection at 265 nm. The recoveries ranged from 83.2% to 88.2% in samples fortified between 5 to 40 ppb levels.     

High-performance liquid chromatography of apolipoproteins in serum high-density lipoproteins

A simple and rapid method for apolipoprotein analysis in serum high-density lipoproteins (HDL) has been developed using high-performance liquid chromatography (HPLC) with sodium phosphate buffer (pH 7.0) containing 0.1% sodium dodecyl sulphate (SDS) as eluent. In contrast to the use of urea solution as an eluent, apolipoproteins can be analysed by applying an incubation mixture of HDL and the eluent buffer. A TSK-GEL column of G3000SW was found to be more profitable than G2000SW or G4000SW for analysis of HDL apolipoproteins. Elution patterns monitored by absorbance at 280 nm using a G3000SW column can give precise quantitative as well as qualitative information about apolipoproteins of molecular weight between 10(4) and 10(5). HPLC patterns of HDL apolipoproteins were compared between individual human subjects with various diseases. Elution profiles for lipid components in an incubation mixture were also examined.     

Ion-exchange high-performance liquid chromatographic purification of bovine cardiac and rabbit skeletal muscle troponin subunits

Bovine cardiac and rabbit skeletal troponin complexes were separated into their respective subunits employing high-performance liquid chromatographic (HPLC) techniques on CM-300 and Q-300 ion-exchangers. Bovine cardiac and rabbit skeletal subunits were separated on the strong anion-exchanger, Q-300, in 8 M urea, 50 mM Tris, 2 mM EGTA, 0.5 mM dithiothreitol, pH 7.5, employing a linear salt gradient and on the weak cation-exchanger, CM-300, in 8 M urea, 50 mM potassium dihydrogen phosphate, 2 mM EGTA, 0.5 mM dithiothreitol, pH 6.5, using a linear salt gradient. To obtain complete purification of all components of troponin both ion-exchangers were required. The initial separation of troponin was carried out on the strong anion-exchanger followed by weak cation-exchange chromatography of the troponin I collected from the strong anion-exchange column. The troponin T subunits obtained from Q-300 chromatography demonstrated heterogeneity (three components: T1, T2 and T3) while the troponin I collected from both sources on the Q-300 column were both resolved into major doublets (I1 and I2) when rechromatographed on the CM-300 column. The three troponin T fractions and two troponin I fractions isolated from ion-exchange HPLC were examined by sodium dodecyl sulfate-urea polyacrylamide gel electrophoresis and two-dimensional gel electrophoresis to confirm that the heterogeneity was due to differences in charge and not molecular weight. These results were in agreement with the charge differences observed from retention times on ion-exchange HPLC. When comparing the same troponin subunit from different muscle sources, considerable differences in the content of charged amino acid residues were also observed.     

High-performance liquid chromatographic determination of N-methylformamide and N-methyl-N-(hydroxymethyl)-formamide in human urine.

A reliable high-performance liquid chromatographic (HPLC) method which allows the determination in human urine of two important metabolites of N,N-dimethylformamide (DMF), namely N-methylformamide (MMF) and N-methyl-N-(hydroxymethyl)formamide (DMFOH), is reported. A single-step rapid purification of urine was performed on a C18 solid-phase extraction column and the eluate was injected directly on to the HPLC column. HPLC was carried out isocratically on Aminex Ion Exclusion HPX-87H column using 7.5.10(-4) M sulphuric acid as the mobile phase with ultraviolet detection at 196 nm. The method is specific, accurate, precise and sufficiently sensitive to be applied to the biological monitoring of MMF and DMFOH in workers exposed to DMF.     

Hydrophobic interaction fast protein liquid chromatography of milk proteins

Bovine whey proteins and caseins were separated by hydrophobic interaction chromatography with the new Pharmacia fast protein liquid chromatography column, phenyl-Superose. Total casein was separated using a decreasing gradient of 0.8 to 0.05 M sodium phosphate and a constant 3.75 M urea concentration at pH 6.0. The order of elution of caseins was beta less than gamma, alpha s2 less than kappa less than alpha s1, and beta-casein was always eluted first. Whey proteins were separated with a decreasing salt gradient of 1.5 to 0 M ammonium sulphate in 0.05 M sodium phosphate at pH 7.0. The order of elution was beta-lactoglobulin less than bovine serum albumin less than immunoglobulin less than alpha-lactalbumin. The elution order of proteins from the column did not correlate with the calculated average hydrophobicities but the method was considered to be a measure of the "effective" hydrophobicity of proteins and therefore of more use for attempting to relate hydrophobicity to functional properties of proteins. The method shows significant advantages over conventional techniques allowing rapid optimization of elution conditions and reducing run times from 24 h or more to less than 2 h.     

The Determination of Folic Acid (Pteroylmonoglutamic Acid) in Fortified Products by Reversed Phase High Pressure Liquid Chromatography

Abstract

A reversed phase HPLC method was developed for the separation and determination of pteroylglutamic acid (PGA) in fortified foods. Extraction was carried out by heating with phosphate-citrate buffer, pH 8.0 containing ascorbate, and incubation with papain at 40°C for 4 hrs. The extracts were purified and concentrated on a short DEAE column which was rinsed with phosphate buffer, pH 7.0, of increasing molarity. PGA was eluted with 0.1M phosphate buffer, pH 7.0, containing 0.5M NaCl. The eluants were chromatographed on a Spherisorb ODS 10 μm column (250 × 4.6 mm) using a 30 min linear gradient of 2% to 30% acetonitrile in 0.1M acetate buffer, pH 4.0, at 1 ml/min and an absorbance detector at 280 nm. The coefficients of variation on analysis of 8 replicate samples of a milk and soy protein based infant formulas were 5.9% (at 4.6 ng/50 μl inject) and 6.8% (at 1.8 ng/50 μl inject) respectively.     

High Performance Liquid Chromatographic Analysis of Penicillin V Solid Dosage Forms

Abstract

An isocratic high performance liquid chromatographic (HPLC) method for the determination of Penicillin V in solid dosage forms is described. A reverse phase RP-8 column and a mobile phase of 52% methanol in 0.05 M phosphate buffer (pH 3.3) were employed. Detection was effected at 254 nm. The results obtained are compared with those from the iodometric method.